Euro Radio颈动脉易损斑块与脑小血管疾病及急性缺血性卒中的相关性

2022-08-22 shaosai MedSci原创

斑块内出血(IPH)、薄或破裂的纤维帽(FC)和不规则的斑块表面等易损斑块特征是评估缺血性卒中风险的有效指标。

众所周知卒中是世界范围内导致死亡和残疾的主要原因之一,大动脉粥样硬化和小血管闭塞都可能导致急性缺血性卒中(AIS)。以往的一些研究表明,斑块内出血(IPH)、薄或破裂的纤维帽(FC)和不规则的斑块表面易损斑块特征是评估缺血性卒中风险的有效指标。小血管闭塞是脑小血管疾病(CSVDs)的病理之一,占缺血性卒中的25%。越来越多的证据表明,白质增生(WMHs)和裂隙由MRI确定的CSVDs与缺血性卒中的风险明显相关。虽然颈动脉粥样硬化和CSVDs是不同的血管疾病,但许多研究者发现这些疾病常在有脑血管症状的患者中并存。

研究证明,大动脉粥样硬化狭窄患者的CSVDs与脑血管事件之间存在关联。然而,目前还不清楚与CSVDs共存的颈动脉粥样硬化的易损斑块特征是否比单独的斑块特征与AIS有更强的关联。

近日,发表European Radiology杂志的一项研究探讨了与CSVDs共存的颈动脉易损斑块特征与AIS风险之间的关系,并进一步确定了共存的疾病与AIS的关系是否比单一疾病更加密切,为临床进一步阐明两种疾病的病理生理及进展因素提供了参考依据。

本研究招募了同时患有脑血管症状和颈动脉斑块的患者进入研究。该人群被分为两组(AIS和短暂性缺血性卒中(TIA))。评估了颈动脉斑块(包括管腔狭窄和斑块易损性)和CSVDs(如白质增生(WMHs)和裂隙)的MRI特征。并存的疾病被定义为至少存在一个颈动脉斑块特征和一个或多个CSVDs特征。进行多变量逻辑回归,研究共存疾病和AIS之间的关联。 

在招募的634名患者中(平均年龄:59.1±11.3岁;429名男性),312名(49.2%)患者患有AIS。与TIA患者相比,这些受试者的颈动脉易损斑块、裂隙和中重度WMH(Fazekas总分3-6分)的发生率更高(分别为42.6% vs. 29.5%,59.6% vs. 26.4%,69.9% vs. 60.6%,所有P<0.05)。多变量分析显示,与单独的颈动脉病变相比,颈动脉斑块特征与裂隙或中重度WMHs共存与AIS有更强的关联(均为P<0.05)(即易损斑块与裂隙共存与单独的易损斑块,调整后的几率比:3.67 vs. 1.62)。 

 
图 a(Fazekas总分:0),脑室周围或深部白质没有观察到高信号。 b(Fazekas总分:2),深部白质的点状高信号(白色箭头)(Fazekas评分:1)和脑室周围的帽状高信号(白色箭头)(Fazekas评分:1)。c(Fazekas总分:3),可以看到深层白质高信号(Fazekas评分:2)和脑室周围的帽状高信号(Fazekas评分:1,白色箭头)开始汇合。 d(Fazekas总分:6),脑室周围病变(白色箭头)延伸到深层白质(Fazekas评分:3),深层白质中出现大量病变(白色箭头)汇合(Fazekas评分:3)

本研究发现,与单独的颈动脉疾病相比,颈动脉易损斑块及脑小血管疾病与急性缺血性卒中有更强的关联。本研究结果表明,全面评估颈动脉斑块的易损性和脑小血管疾病有助于更好地对缺血性卒中进行风险分层。

 

原文出处:

Jin Li,Hengqu Wu,Hailun Hang,et al.Carotid vulnerable plaque coexisting with cerebral small vessel disease and acute ischemic stroke: a Chinese Atherosclerosis Risk Evaluation study.DOI:10.1007/s00330-022-08757-9

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
    2023-03-24 feather89
  6. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1893539, encodeId=21b818935395c, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Dec 23 01:59:03 CST 2022, time=2022-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838099, encodeId=ceef1838099bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Feb 17 03:59:03 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806536, encodeId=50a61806536ce, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Fri May 26 21:59:03 CST 2023, time=2023-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774681, encodeId=840f1e74681b7, content=<a href='/topic/show?id=d0e24e171d1' target=_blank style='color:#2F92EE;'>#小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47171, encryptionId=d0e24e171d1, topicName=小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c7a38663370, createdName=kord1995, createdTime=Sun Sep 25 06:59:03 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729747, encodeId=3d461e2974757, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Mar 24 17:59:03 CST 2023, time=2023-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843672, encodeId=81b718436e235, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Mon May 08 01:59:03 CST 2023, time=2023-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330254, encodeId=4255133025416, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480877, encodeId=93b114808e77d, content=<a href='/topic/show?id=de508482e61' target=_blank style='color:#2F92EE;'>#脑小血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84827, encryptionId=de508482e61, topicName=脑小血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76c57719730, createdName=thinkibmz_44722596, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499108, encodeId=30f3149910844, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 24 02:59:03 CST 2022, time=2022-08-24, status=1, ipAttribution=)]

相关威廉亚洲官网

Eur Radiol:如何应用斑块特征和血流动力学差异预测缺血性卒中的临床预后?

脑卒中是全球第二大常见死亡原因,缺血性卒中约占全部卒中的80%。颈动脉或颅内动脉粥样硬化是缺血性脑卒中发生的重要原因。

易损斑块的影像学研究进展-解读PROSPECT研究

    心血管疾病是发达国家人民致死的主要原因,同时也是发展中国家的头号杀手。据统计,每年美国100多万人,全球1900多万人经历突发性心脏事件(急性冠状动脉综合征(ACS) 和/或心脏性猝死)。进入本世纪以来,心血管疾病已成为我国的第一位杀手。近年的研究发现,导致急性心血管事件的主要原因是动脉粥样硬化(AS)斑块破裂和血栓形成,后者取决于AS斑块的不稳定性,即易损性

TCT 2020丨PROSPECT Ⅱ/ABSORB研究:易损斑块的预防性PCI?

经血管内超声和近红外光谱鉴定的易损斑块患者发生重大心血管不良事件的风险显着增加。希望有一天CT血管造影能够被用来识别那些有富含脂质的易损斑块的潜在高危患者,然后将其转诊以进行更明确的血管内成像。

JACC:ACC前主席痛批“易损斑块”理念!脂质斑块与远期事件无关

富含脂质的斑块属于高危斑块。对于脂质斑块罪犯病变的介入治疗,一些病理学研究提示会出现远端栓塞和损伤部位愈合而恶化预后。

AHA2019丨STEMI患者的非罪犯血管斑块形态:COMPLETE试验OCT亚组研究结果

11月17日,在2019美国心脏协会科学年会(AHA 2019)上,来自美国人口健康研究协会、McMaster大学和汉密尔顿健康科学研究所的Natalia Pinilla-Echeverri教授发表主题报告,阐述ST段抬高型心肌梗死(STEMI)患者的非罪犯血管斑块形态的OCT特点。